OBJECTIVE: Coronary angiography using multidetector computed tomography (MDCT) allows non-invasive assessment of non-calcified, calcified and mixed plaques. Progression of coronary plaques may be influenced by statins. METHODS: Sixty-three consecutive patients underwent MDCT as a follow-up to their original CT angiography in a retrospective longitudinal study. MDCT was performed by using a voxel size of 0.5 × 0.35 × 0.35 mm(3) at two time points 25 ± 3 months apart. Non-calcified, calcified and mixed coronary plaque components were analysed by using volumetric measurement. The influence of statin, low-density lipoprotein (LDL) and risk factors was assessed by using a linear random intercept model for plaque growth. RESULTS: The volumes of non-calcified, calcified and mixed coronary plaques significantly (P < 0.001) increased from baseline (medians/interquartile ranges = 21/15-39, 7/3-20 and 36/16-69 mm(3)) to follow-up (29/17-44, 13/6-29 and 41/20-75 mm(3)). Statins significantly slowed the growth of non-calcified plaques (statin coefficient β = -0.0036, P = 0.01) but did not significantly affect the growth rate of mixed or calcified plaques. The effect of statin treatment on non-calcified plaques remained significant after adjusting for LDL levels and cardiac risk factors. CONCLUSION: Quantification using MDCT shows that progression of non-calcified coronary plaques may be slowed by statins.
OBJECTIVE: Coronary angiography using multidetector computed tomography (MDCT) allows non-invasive assessment of non-calcified, calcified and mixed plaques. Progression of coronary plaques may be influenced by statins. METHODS: Sixty-three consecutive patients underwent MDCT as a follow-up to their original CT angiography in a retrospective longitudinal study. MDCT was performed by using a voxel size of 0.5 × 0.35 × 0.35 mm(3) at two time points 25 ± 3 months apart. Non-calcified, calcified and mixed coronary plaque components were analysed by using volumetric measurement. The influence of statin, low-density lipoprotein (LDL) and risk factors was assessed by using a linear random intercept model for plaque growth. RESULTS: The volumes of non-calcified, calcified and mixed coronary plaques significantly (P < 0.001) increased from baseline (medians/interquartile ranges = 21/15-39, 7/3-20 and 36/16-69 mm(3)) to follow-up (29/17-44, 13/6-29 and 41/20-75 mm(3)). Statins significantly slowed the growth of non-calcified plaques (statin coefficient β = -0.0036, P = 0.01) but did not significantly affect the growth rate of mixed or calcified plaques. The effect of statin treatment on non-calcified plaques remained significant after adjusting for LDL levels and cardiac risk factors. CONCLUSION: Quantification using MDCT shows that progression of non-calcified coronary plaques may be slowed by statins.
Authors: Alexander W Leber; Andreas Knez; Carl W White; Alexander Becker; Franz von Ziegler; Olaf Muehling; Christoph Becker; Maximilian Reiser; Gerhard Steinbeck; Peter Boekstegers Journal: Am J Cardiol Date: 2003-03-15 Impact factor: 2.778
Authors: Stefan C Saur; Hatem Alkadhi; Paul Stolzmann; Stephan Baumüller; Sebastian Leschka; Hans Scheffel; Lotus Desbiolles; Thomas J Fuchs; Gábor Székely; Philippe C Cattin Journal: Eur Radiol Date: 2010-01-30 Impact factor: 5.315
Authors: W G Austen; J E Edwards; R L Frye; G G Gensini; V L Gott; L S Griffith; D C McGoon; M L Murphy; B B Roe Journal: Circulation Date: 1975-04 Impact factor: 29.690
Authors: Abel Romero-Corral; Victor M Montori; Virend K Somers; Josef Korinek; Randal J Thomas; Thomas G Allison; Farouk Mookadam; Francisco Lopez-Jimenez Journal: Lancet Date: 2006-08-19 Impact factor: 79.321
Authors: Christof Burgstahler; Anja Reimann; Torsten Beck; Axel Kuettner; Dorothee Baumann; Martin Heuschmid; Harald Brodoefel; Claus D Claussen; Andreas F Kopp; Stephen Schroeder Journal: Invest Radiol Date: 2007-03 Impact factor: 6.016
Authors: Fabian Bamberg; Nina Dannemann; Michael D Shapiro; Sujith K Seneviratne; Maros Ferencik; Javed Butler; Wolfgang Koenig; Khurram Nasir; Ricardo C Cury; Ahmed Tawakol; Stephan Achenbach; Thomas J Brady; Udo Hoffmann Journal: Arterioscler Thromb Vasc Biol Date: 2008-01-03 Impact factor: 8.311
Authors: Steven E Nissen; E Murat Tuzcu; Paul Schoenhagen; B Greg Brown; Peter Ganz; Robert A Vogel; Tim Crowe; Gail Howard; Christopher J Cooper; Bruce Brodie; Cindy L Grines; Anthony N DeMaria Journal: JAMA Date: 2004-03-03 Impact factor: 56.272
Authors: Michael Schmid; Stephan Achenbach; Dieter Ropers; Sei Komatsu; Ulrike Ropers; Werner G Daniel; Tobias Pflederer Journal: Am J Cardiol Date: 2007-12-21 Impact factor: 2.778
Authors: Stella-Lida Papadopoulou; Hector M Garcia-Garcia; Alexia Rossi; Chrysafios Girasis; Anoeshka S Dharampal; Pieter H Kitslaar; Gabriel P Krestin; Pim J de Feyter Journal: Int J Cardiovasc Imaging Date: 2012-12-07 Impact factor: 2.357
Authors: L La Grutta; M Galia; G Gentile; G Lo Re; E Grassedonio; F Coppolino; E Maffei; E Maresi; A Lo Casto; F Cademartiri; M Midiri Journal: Br J Radiol Date: 2013-01 Impact factor: 3.039